Biomet in tissue-engineered product deal
This article was originally published in Clinica
Executive Summary
Orthopaedics company Biomet is to gain worldwide rights to develop and commercialise orthopaedic and periodontal products using Organogenesis' FortaFlex bioengineered collagen matrix technology. Organogenesis gets undisclosed royalties on net sales.